Figure 2 from Identification of a Cytokine Biomarker for Prognostic Modeling of Breast Cancer–Related Lymphedema

2026 Open access

Read full text
Authors: Alison J. Wu, Neil Lin, Jie Susie Su, Cherie Xinyi. Lin, M. R. Hossack, Wei Shi, Farnoosh Abbas Aghababazadeh, Wei Xu, Benjamin Haibe‐Kains, Simona Flora Shaitelman, Melissa B. Aldrich, Fei-Fei Liu
+1 more Jennifer Y. Y. Kwan
DOI: 10.1158/2767-9764.31452943
Cited by: 0

Abstract

IFNα2 levels in patients with breast cancer. Preradiotherapy IFNα2 was measured in 62 patients with breast cancer. Patients were grouped by their lymphedema (LE) status at 18 months after cancer treatment. Data are plotted as median with IQR. Two-tailed P value is 0.157 (Mann–Whitney test).

Fields of Study & Subjects

Lymphatic System and Diseases Breast Cancer Treatment Studies Inflammatory Biomarkers in Disease Prognosis

Publication details

Publication date
3 March 2026
Language
EN